Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (361-370 of 403) with videos related to

Pageof 41
Sort By:
Plos Pathogens|November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen moleculesSteven Johnson, Lionel Tan, Stijn van der Veen, et al.
Vaccine|August 18, 2012
Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trialSiddhivinayak Hirve, Ashish Bavdekar, Anand Pandit, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groupsSusan K Hoiseth, Ellen Murphy, Lubomira Andrew, et al.
The Journal of Infection|November 3, 2024
Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western EuropeRay Borrow, Helen Campbell, Dominique A Caugant, et al.
JMIR Public Health and Surveillance|April 3, 2020
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health EnglandSimon de Lusignan, Jamie Lopez Bernal, Maria Zambon, et al.
IJID Regions|May 8, 2026
Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024)Lamia Al-Kershi, Deema Al Bakri, Zeina Abdel Majeed, et al.
Eclinicalmedicine|August 13, 2021
SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020Shamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
Pageof 41

Showing results (361-370 of 403) with videos related to

Sort By:
Pageof 41
Plos Pathogens|November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen moleculesSteven Johnson, Lionel Tan, Stijn van der Veen, et al.
Vaccine|August 18, 2012
Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trialSiddhivinayak Hirve, Ashish Bavdekar, Anand Pandit, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groupsSusan K Hoiseth, Ellen Murphy, Lubomira Andrew, et al.
The Journal of Infection|November 3, 2024
Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western EuropeRay Borrow, Helen Campbell, Dominique A Caugant, et al.
JMIR Public Health and Surveillance|April 3, 2020
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health EnglandSimon de Lusignan, Jamie Lopez Bernal, Maria Zambon, et al.
IJID Regions|May 8, 2026
Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024)Lamia Al-Kershi, Deema Al Bakri, Zeina Abdel Majeed, et al.
Eclinicalmedicine|August 13, 2021
SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020Shamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
Pageof 41